These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8462686)

  • 21. Effects of a 2,3-oxidosqualene-lanosterol cyclase inhibitor 2,3:22,23-dioxidosqualene and 24,25-epoxycholesterol on the regulation of cholesterol biosynthesis in human hepatoma cell line HepG2.
    Dollis D; Schuber F
    Biochem Pharmacol; 1994 Jul; 48(1):49-57. PubMed ID: 8043030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and inhibition studies of sulfur-substituted squalene oxide analogues as mechanism-based inhibitors of 2,3-oxidosqualene-lanosterol cyclase.
    Stach D; Zheng YF; Perez AL; Oehlschlager AC; Abe I; Prestwich GD; Hartman PG
    J Med Chem; 1997 Jan; 40(2):201-9. PubMed ID: 9003518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of 2,3-oxidosqualene cyclases.
    Taton M; Benveniste P; Rahier A; Johnson WS; Liu HT; Sudhakar AR
    Biochemistry; 1992 Sep; 31(34):7892-8. PubMed ID: 1510977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2,3-Oxidosqualene cyclase: from azasqualenes to new site-directed inhibitors.
    Cattel L; Ceruti M; Balliano G; Viola F; Grosa G; Rocco F; Brusa P
    Lipids; 1995 Mar; 30(3):235-46. PubMed ID: 7791532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro susceptibility of fungi to acyclic inhibitors of 2,3-oxidosqualene cyclases.
    Airaudi D; Ceruti M; Bianco C; Filipello Marchisio V
    Mycoses; 1996; 39(1-2):51-6. PubMed ID: 8786759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vinyl sulfide derivatives of truncated oxidosqualene as selective inhibitors of oxidosqualene and squalene-hopene cyclases.
    Ceruti M; Balliano G; Rocco F; Milla P; Arpicco S; Cattel L; Viola F
    Lipids; 2001 Jun; 36(6):629-36. PubMed ID: 11485168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in the inhibitory effects of N-(1-n-dodecyl)-heterocycles on the 2,3-oxidosqualene lanosterol-cyclase of rat liver and yeast.
    Mercer EI; Morris PK; Baldwin BC
    Comp Biochem Physiol B; 1985; 80(2):341-6. PubMed ID: 3884249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Saccharomyces cerevisiae oxidosqualene-lanosterol cyclase: a chemistry-biology interdisciplinary study of the protein's structure-function-reaction mechanism relationships.
    Wu TK; Chang CH; Liu YT; Wang TT
    Chem Rec; 2008; 8(5):302-25. PubMed ID: 18956480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analogs of squalene and oxidosqualene inhibit oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae.
    Oliaro-Bosso S; Ceruti M; Balliano G; Milla P; Rocco F; Viola F
    Lipids; 2005 Dec; 40(12):1257-62. PubMed ID: 16477810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of cholesterol biosynthesis in Chinese hamster ovary cells by 4,4,10 beta-trimethyl-trans-decal-3 beta-ol. A specific 2,3-oxidosqualene cyclase inhibitor.
    Chang TY; Schiavoni ES; McCrae KR; Nelson JA; Spencer TA
    J Biol Chem; 1979 Nov; 254(22):11258-63. PubMed ID: 500643
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of 2,3-iminosqualene on cultured cells.
    Popják G; Meenan A; Nes WD
    Proc R Soc Lond B Biol Sci; 1987 Dec; 232(1268):273-87. PubMed ID: 2894034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preferential cyclization of 2,3(S):22(S),23-dioxidosqualene by mammalian 2,3-oxidosqualene-lanosterol cyclase.
    Boutaud O; Dolis D; Schuber F
    Biochem Biophys Res Commun; 1992 Oct; 188(2):898-904. PubMed ID: 1445330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequence of the Candida albicans erg7 gene.
    Roessner CA; Min C; Hardin SH; Harris-Haller LW; McCollum JC; Scott AI
    Gene; 1993 May; 127(1):149-50. PubMed ID: 8486282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Squalene analogues containing isopropylidene mimics as potential inhibitors of pig liver squalene epoxidase and oxidosqualene cyclase.
    Sen SE; Prestwich GD
    J Med Chem; 1989 Sep; 32(9):2152-8. PubMed ID: 2769687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory activity of 8-azadecalin derivatives towards 2,3-oxidosqualene:lanosterol cyclases from baker's yeast and pig's liver.
    Hoshino T; Kobayashi N; Ishibashi E; Hashimoto S
    Biosci Biotechnol Biochem; 1995 Apr; 59(4):602-9. PubMed ID: 7772824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary screening of some squalenoid derivatives for toxicity towards dermatophytes.
    Airaudi D; Ceruti M; Giannetta A; Filipello Marchisio V
    Mycoses; 1995; 38(7-8):311-5. PubMed ID: 8559196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cloning and characterization of the 2,3-oxidosqualene cyclase-coding gene of Candida albicans.
    Kelly R; Miller SM; Lai MH; Kirsch DR
    Gene; 1990 Mar; 87(2):177-83. PubMed ID: 2185141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conjugated methyl sulfide and phenyl sulfide derivatives of oxidosqualene as inhibitors of oxidosqualene and squalene-hopene cyclases.
    Rocco F; Bosso SO; Viola F; Milla P; Roma G; Grossi G; Ceruti M
    Lipids; 2003 Mar; 38(3):201-7. PubMed ID: 12784859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a supernatant protein on microsomal squalene epoxidase and 2,3-oxidosqualene-lanosterol cyclase.
    Saat YA; Bloch KE
    J Biol Chem; 1976 Sep; 251(17):5155-60. PubMed ID: 956181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yeast oxidosqualene cyclase (Erg7p) is a major component of lipid particles.
    Milla P; Athenstaedt K; Viola F; Oliaro-Bosso S; Kohlwein SD; Daum G; Balliano G
    J Biol Chem; 2002 Jan; 277(4):2406-12. PubMed ID: 11706015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.